"Virginia Oncology Associates is an oncology and hematology practice of physicians, specializing in the diagnosis and treatment of cancer and blood disorders. With locations spanning the southeast region of Virginia and Northeastern North Carolina, we are able to extend services and treatments to patients, including medical oncology, radiation oncology, gynecologic oncology, hematology, diagnostics, clinical research, stem cell transplantation, genetic counseling, and psychosocial oncology."

During the past decade, Virginia Oncology Associates conducted 89 clinical trials. In the 10-year time frame, 89 clinical trials started and 70 clinical trials were completed, i.e. on average, 78.7% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 33 clinical trials were completed. i.e. 78.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Oncology Associates" #1 sponsor was "US Oncology Research" with 15 trials, followed by "Hoffmann-La Roche" with 14 trials sponsored, "Pfizer" with 13 trials sponsored, "Novartis Pharmaceuticals" with 9 trials sponsored and "Janssen Research & Development, LLC" with 9 trials sponsored. Other sponsors include 130 different institutions and companies that sponsored additional 87 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Oncology Associates" #1 collaborator was "Bristol-Myers Squibb" with 8 trials as a collaborator, "Sanofi" with 8 trials as a collaborator, "Merck Sharp & Dohme LLC" with 6 trials as a collaborator, "Astellas Pharma Inc" with 5 trials as a collaborator and "Hoosier Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Oncology Associates" are "Breast Cancer" (19 trials), "Prostate Cancer" (19 trials), "Metastatic Breast Cancer" (14 trials), "Ovarian Cancer" (10 trials) and "Multiple Myeloma" (6 trials). Many other conditions were trialed in "Virginia Oncology Associates" in a lesser frequency.

Most popular intervention types in "Virginia Oncology Associates" are "Drug" (184 trials), "Biological" (10 trials), "Other" (10 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Paclitaxel" (20 trials), "Carboplatin" (13 trials), "Gemcitabine" (13 trials) and "Docetaxel" (12 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Oncology Associates" are 127 trials for "All" genders, 33 trials for "Male" genders and 31 trials for "Female" genders.

Currently, there are NaN active trials in "Virginia Oncology Associates". undefined are not yet recruiting, 22 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 108 completed trials in Virginia Oncology Associates, undefined suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Oncology Associates, 47 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 81 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Virginia Oncology Associates has several departments that took part in Clinical trials: "Virginia Oncology Associates-Hampton" - 56 trials, "Virginia Oncology Associates" - 2 trials, "Virginia Oncology Associates - Norfolk" - 28 trials, "Virginia Oncology Associates - Lake Wright" - 21 trials, "Hematology & Oncology Associates of Virginia" - 4 trials